[Microbiological evaluation of salicyclic acid and other broad spectrum antimicrobials].
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000592:standards; D000891:Anti-Infective Agents, Local / Q000494:pharmacology*; D003883:Arthrodermataceae / Q000187:drug effects*; D001414:Bacitracin / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D002176:Candida albicans / Q000187:drug effects; D007464:Clioquinol / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D007239:Infections / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D010866:Natamycin / Q000494:pharmacology; D012459:Salicylates / Q000494:pharmacology*; D012871:Skin Diseases / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D014047:Tolnaftate / Q000494:pharmacology; D014249:Trichophyton / Q000187:drug effects; D014476:Undecylenic Acids / Q000494:pharmacology; D015003:Yeasts / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000891:Anti-Infective Agents, Local; D005839:Gentamicins; D012459:Salicylates; D014476:Undecylenic Acids; D014047:Tolnaftate; D001414:Bacitracin; D007464:Clioquinol; D010866:Natamycin
Mikrobiologische Evaluierung der Salizylsäure und anderer Breitspektrum-Antimikrobika.